Receive Our Newsletter

Incivek (telaprevir) In Combination with Drugs Peginterferon Alfa and Ribavirin (Incivek Combination Treatment): Drug Safety Communication – Serious Skin Reactions

AUDIENCE: Internal Medicine, Gastroenterology, Dermatology ISSUE: FDA received reports of serious skin reactions, some fatal, in patients taking the hepatitis C drug Incivek (telaprevir) in combination with the drugs peginterferon alfa and ribavirin (Incivek combination treatment). Some patients died when they continued to receive Incivek combination treatment after developing a worsening, or progressive rash and […]


Acupuncture: Needles & Hemophilia? Does This Make Sense?

Hemophilia pain It is well known that persons with hemophilia have episodes of painful experiences. Pain results after an acute joint bleed, where the synovial capsule fills with blood and expands with nowhere to go. Once the bleeding is treated with factor,with time the blood in the joint is reabsorbed and the swelling and pain […]

HFA Observes National Hepatitis Awareness Month

HFA Observes National Hepatitis Awareness Month FOR IMMEDIATE RELEASE: May 3, 2012 Contact: Richard Pezzillo (202)-675-6984 Link to PDF of HFA Celebrates Hepatitis Awareness Month Washington, D.C. – In 2001, the Centers for Disease Control (CDC) and Prevention designated the month of May as Hepatitis Awareness Month to bring awareness and attention to those living with viral […]

Living With Hepatitis C

Mark Antell talks candidly about his hemophilia and hepatitis C.

Viral Outbreaks in Dogs Yield Clues on Origins of Hepatitis C

New York Times article link By CARL ZIMMER Published: May 30, 2011 Hepatitis C is, in some ways, a high-profile disease. Worldwide, an estimated 200 million people are infected with the virus. Some of them will suffer cirrhosis, liver cancer and even death. Celebrities like Steven Tyler of Aerosmith and “American Idol” have spoken publicly […]

Merck’s Hepatitis C Drug Wins F.D.A. Approval

Click here for New York Times article. By ANDREW POLLACK Published: May 13, 2011 The Food and Drug Administration approved on Friday the first of a new generation of hepatitis C drugs that promises to increase the cure rate while shortening the time required for treatment. The new drug, Victrelis from Merck, effectively cured more […]

Valeant, Kadmon sign deals on hepatitis C drugs

Link to article Mon Nov 1, 2010 11:01am EDT TORONTO (Reuters) – Canada’s Valeant Pharmaceuticals International (VRX.TO: Quote) and U.S. company Kadmon Pharmaceuticals said on Monday they have signed two deals to partner on hepatitis C drugs as Valeant moves to end development of antiviral drugs but seeks to bolster its offering of already commercialized […]

WebMD: "New Hepatitis C Drugs in the Works"

Click here for full article Hepatitis Health Center New Hepatitis C Drugs in the Works Study Show 2 Experimental Drugs Are Able to Reduce Virus Levels in Blood By Salynn Boyles WebMD Health News Reviewed by Laura J. Martin, MD Oct. 14, 2010 — The long wait for new drugs that cure hepatitis C virus […]

May is National Hepatitis Month

May is National Hepatitis Month Earlier this year the Institute of Medicine (IOM) released a report on Viral Hepatitis in the United States and called for efforts to increase knowledge and awareness of this major public health problem. During the month of May, CDC and our public health partners are celebrating the 15th anniversary of […]

Page 10 of 1012345678910

Assisting and Advocating for the Bleeding Disorders Community